News
Welsh firm Antiverse raises funds for AI antibody platform
Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.
News
Five projects share £100m UK-US Cancer Grand Challenges fund
Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
News
Moderna agrees $950m settlement of mRNA jab litigation
Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.
News
Cancer risk scuppers Kyowa Kirin's autoimmune disease drug
Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in patients taking the drug.
News
UK puts £50m behind expanded clinical trials drive
The UK has awarded nearly £50m in funding for equipment to help the NHS carry out commercial clinical trials, with a focus on primary care capacity.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
